Monogene and Polygene Therapy for the Treatment of Experimental Prostate Cancers by Use of Apoptotic Genes bax and bad Driven by the Prostate-Specific Promoter ARR2PB
Susan Kasper
Human Gene Therapy, 2002
View PDFchevron_right
Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells
M. Bosseler, Guy Berchem
Cancer research, 1995
View PDFchevron_right
Androgen and Its Receptor Promote Bax-Mediated Apoptosis
Fangming Tang
Molecular and Cellular Biology, 2006
View PDFchevron_right
Antiandrogens inhibit human androgen receptor-dependent gene transcription activation in the human prostate cancer cells LNCaP
Michael Koutsilieris
The Prostate, 1994
View PDFchevron_right
Androgen blocks apoptosis of hormone-dependent prostate cancer cells
Edward Gelmann
Cancer research, 2001
View PDFchevron_right
Androgen receptor expression in relation to apoptosis and the expression of cell cycle related proteins in prostate cancer
Ahmad Monabati
Pathology & Oncology Research, 2004
View PDFchevron_right
Antiandrogen-induced cell death in LNCaP human prostate cancer cells
Martin Tenniswood, Kathryn Packman
Cell Death and Differentiation, 2003
View PDFchevron_right
Suppression of default apoptosis in androgen‐dependent cells by testosterone‐mediated bcl‐2 expression
Masahiro Iida
International Journal of Urology, 1999
View PDFchevron_right
Androgen receptor levels during progression of prostate cancer in the transgenic adenocarcinoma of mouse prostate model
Krisna Murti
Medical Journal of Indonesia, 2010
View PDFchevron_right
Resistance to Apoptosis and Up Regulation of Bcl-2 In Benign Prostatic Hyperplasia After Androgen Deprivation
Guy Berchem
The Journal of Urology, 1997
View PDFchevron_right
Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP
farida mebarki
The Journal of Steroid Biochemistry and Molecular Biology, 1995
View PDFchevron_right
The Xenoestrogen Bisphenol A Induces Inappropriate Androgen Receptor Activation and Mitogenesis in Prostatic Adenocarcinoma Cells 1 This work was supported by NIH Training Grant ES07250-13 (to Y. B. W.; Environmental Mutagenesis and Cancer) and NIH Grant R01 CA93404-01 (to K. E. K.).1
Karen Knudsen
Molecular Cancer Therapeutics, 2002
View PDFchevron_right
An elevated bax/bcl-2 ratio corresponds with the onset of prostate epithelial cell apoptosis
Harris Perlman, Ralph Buttyan
Cell Death and Differentiation, 1999
View PDFchevron_right
Increased Expression of Androgen Receptor Sensitizes Prostate Cancer Cells to Low Levels of Androgens
Visa Manni
Cancer Research, 2009
View PDFchevron_right
Androgen receptor (AR) expression in prostate cancer and progression of the tumor: Lessons from cell lines, animal models and human specimens
Pamela Pinzani
Steroids, 2012
View PDFchevron_right
In LNCaP cells enhanced expression of the androgen receptor compensates for Bcl-2 suppression by antisense oligonucleotides
Marvin Rubenstein
Therapeutic advances in urology, 2011
View PDFchevron_right
Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti‐androgens
Pernilla Wikström
The Prostate, 2019
View PDFchevron_right
Membrane Androgen Receptor Activation Induces Apoptotic Regression of Human Prostate Cancer Cells in Vitro and in Vivo
Efstathios Stathopoulos
The Journal of Clinical Endocrinology & Metabolism, 2005
View PDFchevron_right
An Adenovirus Encoding Proapoptotic Bax Induces Apoptosis and Enhances the Radiation Effect in Human Ovarian Cancer
Jesus Gomez-Navarro
Molecular Therapy, 2000
View PDFchevron_right
Androgen receptors in prostate cancer
Helmut Klocker
Endocrine Related Cancer, 2002
View PDFchevron_right
The Role of Androgen Receptor Expression in Prostate Adenocarcinoma
Djumadi Achmad
Open Access Macedonian Journal of Medical Sciences
View PDFchevron_right
Faculty of 1000 evaluation for Androgen receptor is a tumor suppressor and proliferator in prostate cancer
Alvin Matsumoto
F1000 - Post-publication peer review of the biomedical literature, 2008
View PDFchevron_right
Androgen-dependent prostate epithelial cell selection by targeting ARR2PBneo to the LPB-Tag model of prostate cancer
Ren Jin, Simon Hayward
Laboratory Investigation, 2006
View PDFchevron_right
Androgen Receptor Mediates the Reduced Tumor Growth, Enhanced Androgen Responsiveness, and Selected Target Gene Transactivation in a Human Prostate Cancer Cell Line1
Bekir Cinar
Cancer Research, 2001
View PDFchevron_right
Prostatic tumor regrowth after initially successful castration therapy may be related to a decreased apoptotic cell death rate
Jan-erik Damber
Cancer research, 1994
View PDFchevron_right
Mitogenic Action of the Androgen Receptor Sensitizes Prostate Cancer Cells to Taxane-Based Cytotoxic Insult
Karen Knudsen
Cancer Research, 2006
View PDFchevron_right
Androgen receptor alterations in prostatic carcinoma
Helmut Klocker
The Prostate, 1994
View PDFchevron_right
The effect of octreotide and bromocriptine on expression of a pro-apoptotic Bax protein in rat prolactinoma
Marek Pawlikowski
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society, 2004
View PDFchevron_right